Eye drops for early diabetic retinopathy
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study tests whether an experimental eye drop can slow or treat early-stage diabetic retinopathy. If you have diabetes-related vision changes, this treatment might help prevent the condition from getting worse.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 35 and 75 years old.
- You have been diagnosed with diabetes for at least a year.
- You have early-stage diabetic retinopathy (the doctor sees small bulges in the retinal blood vessels).
- You have not had laser treatment or injections in the eye for retinopathy.
- Your vision is better than the level where you can count fingers at a short distance (20/400).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests a treatment aimed at preventing or slowing early diabetic eye disease in people with mild, early changes. You may be considered if your diabetes is moderately controlled and your eye tests show early warning signs.
This is an early-stage safety study testing a new medicine injected directly into the eye to treat diabetic retinopathy (damage to blood vessels in the retina caused by diabetes). The study checks if the medicine is safe and how the body processes it.
This study tests a ginkgo biloba extract (EGb761) to see if it can help prevent or slow early diabetic retinopathy. Participants will receive the extract or a placebo (inactive pill), and their eye health will be monitored over time.
This study tests whether using a special eye scan (OCTA) to guide targeted laser treatment can slow down the progression of areas with poor blood flow in the retina of people with diabetic retinopathy. The goal is to prevent the condition from getting worse and help preserve your vision.
This study tests a new approach aimed at improving diabetic eye disease (diabetic retinopathy). It may help by changing inflammation and related processes in the eye, especially in people who have diabetes and eye changes.
This study looks at how diabetes and eye inflammation are linked in people with diabetic retinopathy (damage to the retina caused by diabetes). By studying fluid samples from the eye during cataract surgery, researchers hope to find new ways to treat or prevent this condition.
Hear when a new Diabetic Retinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.